The Diagnostic and Assessment Value of Plasma Pentraxin 3 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251–272.
   PubMed Web of Science ®Google Scholar
• Lim S, Lam DC, Muttalif AR, et al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14(1):4.
   PubMedGoogle Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global Initiative for Chronic Obstructive Lung D. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185.
   PubMed Web of Science ®Google Scholar
• Garlanda C, Jaillon S, Doni A, Bottazzi B, Mantovani A. PTX3, a humoral pattern recognition molecule at the interface between microbe and matrix recognition. Curr Opin Immunol. 2016;38:39–44.
   PubMed Web of Science ®Google Scholar
• Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med. 2007;204(4):793–804.
   PubMed Web of Science ®Google Scholar
• Lee YT, Gong M, Chau A, et al. International Heath Informatics Study N. Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: a systematic review and meta-analysis. J Infect. 2018;76(1):1–10.
   PubMed Web of Science ®Google Scholar
• Hansen CB, Bayarri-Olmos R, Kristensen MK, Pilely K, Hellemann D, Garred P. Complement related pattern recognition molecules as markers of short-term mortality in intensive care patients. J Infect. 2020;80(4):378–387.
   PubMed Web of Science ®Google Scholar
• Kurt OK, Tosun M, Kurt EB, Talay F. Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease. Inflammation. 2015;38(1):89–93.
   PubMed Web of Science ®Google Scholar
• Poznanski M, Brzezianska-Lasota E, Kiszalkiewicz J, et al. Serum levels and gene expression of pentraxin 3 are elevated in COPD. Adv Med Sci. 2019;64(1):85–89.
   PubMed Web of Science ®Google Scholar
• Beghe B, Verduri A, Bottazzi B, et al. Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational study. PLoS One. 2013;8(11):e80166.
   PubMed Web of Science ®Google Scholar
• Van Pottelberge GR, Bracke KR, Pauwels NS, Vermassen FE, Joos GF, Brusselle GG. COPD is associated with reduced pulmonary interstitial expression of pentraxin-3. Eur Respir J. 2012;39(4):830–838.
   PubMed Web of Science ®Google Scholar
• He Q, Li H, Rui Y, et al. Pentraxin 3 gene polymorphisms and pulmonary aspergillosis in chronic obstructive pulmonary disease patients. Clin Infect Dis. 2018;66(2):261–267.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Singh R, Mackay AJ. Acute COPD exacerbations. Clin Chest Med. 2014;35(1):157–163.
   PubMed Web of Science ®Google Scholar
• Boutet MA, Nerviani A, Lliso-Ribera G, et al. Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response. Front Immunol. 2021;12:686795.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tedrow J, Nouraie M, et al. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers. Thorax. 2021;76(4):335–342.
   PubMed Web of Science ®Google Scholar
• Ching LL, Nerurkar VR, Lim E, Shohet RV, Melish ME, Bratincsak A. Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease. Front Pediatr. 2020;8:295.
   PubMed Web of Science ®Google Scholar
• Vanska M, Koivula I, Hamalainen S, et al. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients. Haematologica. 2011;96(9):1385–1389.
   PubMed Web of Science ®Google Scholar
• Bastrup-Birk S, Skjoedt MO, Munthe-Fog L, Strom JJ, Ma YJ, Garred P. Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome. PLoS One. 2013;8(9):e73119.
   PubMed Web of Science ®Google Scholar
• Moulana Z, Bagherzadeh M, Mirzakhani M, Rostami A, Mohammadnia-Afrouzi M, Shahbazi M. Increased Levels of serum Pentraxin 3 in Critical Coronavirus Disease-2019 Patients. Environ Sci Pollut Res Int. 2022;29(57):85569–85573.
   PubMed Web of Science ®Google Scholar
• Lin TL, Chen WW, Ding ZR, Wei SC, Huang ML, Li CH. Correlations between serum amyloid A, C-reactive protein and clinical indices of patients with acutely exacerbated chronic obstructive pulmonary disease. J Clin Lab Anal. 2019;33(4):e22831.
   PubMed Web of Science ®Google Scholar
• Taylan M, Demir M, Kaya H, et al. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Clin Respir J. 2017;11(3):311–317.
   PubMed Web of Science ®Google Scholar
• Koutsokera A, Stolz D, Loukides S, Kostikas K. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest. 2012;141(2):396–405.
   PubMed Web of Science ®Google Scholar
• Kunes P, Holubcova Z, Kolackova M, Krejsek J. Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm. 2012;2012:920517.
   PubMed Web of Science ®Google Scholar
• Liu J, Pang Z, Wang G, et al. Advanced role of neutrophils in common respiratory diseases. J Immunol Res. 2017;2017:6710278.
   PubMed Web of Science ®Google Scholar
• Grabcanovic-Musija F, Obermayer A, Stoiber W, et al. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir Res. 2015;16:59.
   PubMed Web of Science ®Google Scholar
• Thulborn SJ, Dilpazir M, Haldar K, et al. Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1199–1205.
   PubMed Web of Science ®Google Scholar